Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Viridian Therapeutics, Inc. is a biopharmaceutical company focused on engineering and developing potential medicines for patients with serious and rare diseases. The Company is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The Company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of veligrotug in patients with active and chronic TED. It is also conducting two global Phase 3 clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients. Its advanced program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED. In addition to its TED portfolio, the Company is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.
Find out what a historical investment in VIRIDIAN THERAPEUTICS INC would be worth today using our VRDN stock calculator.
Buying VRDN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in VIRIDIAN THERAPEUTICS INC in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in VRDN
What is the ticker symbol of VIRIDIAN THERAPEUTICS INC?
The ticker symbol for VIRIDIAN THERAPEUTICS INC is VRDN.
How much is one share of VRDN?
One share of VRDN is valued at $31.44 as of 20 November 2026.
What is the market capitalisation of VIRIDIAN THERAPEUTICS INC VRDN?
As of 20 November 2026 VIRIDIAN THERAPEUTICS INC has a market cap of $3.42B.
What is the 52-week high for VIRIDIAN THERAPEUTICS INC stock?
The VIRIDIAN THERAPEUTICS INC 52-week high stock price is $34.29.
What is the 52-week low for VIRIDIAN THERAPEUTICS INC stock?
The VIRIDIAN THERAPEUTICS INC 52-week low stock price is $13.18.
Can I buy VRDN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VRDN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VRDN on Stake
Buy VRDN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of VRDN from only US$10 with fractional shares